VANECK VECTORS ETF TR's ticker is GDX and the CUSIP is 92189F106. A total of 703 filers reported holding VANECK VECTORS ETF TR in Q3 2023. The put-call ratio across all filers is 0.70 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,518,103 | -18.0% | 93,575 | -8.3% | 0.01% | -15.4% |
| Q2 2023 | $3,071,220 | -6.9% | 102,000 | 0.0% | 0.01% | -13.3% |
| Q1 2023 | $3,299,700 | -0.6% | 102,000 | -11.5% | 0.02% | -6.2% |
| Q4 2022 | $3,320,439 | +9.6% | 115,213 | -8.3% | 0.02% | +6.7% |
| Q3 2022 | $3,029,000 | +15.4% | 125,617 | +31.1% | 0.02% | +25.0% |
| Q2 2022 | $2,624,000 | -12.3% | 95,845 | +22.9% | 0.01% | 0.0% |
| Q1 2022 | $2,991,000 | -18.1% | 78,000 | -33.3% | 0.01% | -7.7% |
| Q4 2021 | $3,652,000 | +8.7% | 117,000 | +2.6% | 0.01% | 0.0% |
| Q3 2021 | $3,359,000 | -5.8% | 114,000 | +8.6% | 0.01% | 0.0% |
| Q2 2021 | $3,567,000 | -13.6% | 105,000 | -17.3% | 0.01% | -18.8% |
| Q1 2021 | $4,127,000 | +44.4% | 127,000 | +58.8% | 0.02% | +33.3% |
| Q4 2020 | $2,859,000 | – | 80,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Harbor Financial Group, LLC | 1,221,955 | $36,011,000 | 14.81% |
| New Harbor Financial Group, LLC | 1,155,900 | $34,064,000 | 14.01% |
| Memorial Sloan Kettering Cancer Center | 738,500 | $21,764,000 | 13.56% |
| Hollow Brook Wealth Management LLC | 670,275 | $19,753,000 | 12.24% |
| Grand Central Investment Group | 293,243 | $8,642,000 | 11.46% |
| BW Gestao de Investimentos Ltda. | 940,800 | $27,725,000 | 8.44% |
| Slate Path Capital LP | 5,930,000 | $174,757,000 | 7.97% |
| Nokomis Capital, L.L.C. | 512,628 | $15,107,000 | 7.14% |
| Plaisance Capital LLC | 288,000 | $8,487,000 | 6.05% |
| Guild Investment Management, Inc. | 200,114 | $5,897,000 | 5.68% |